In this position, Andrew will spearhead the development of Integrated Graphene’s global manufacturing capabilities, facilitating the international commercial sales of Gii across North America, Europe, the Middle East, and Asia-Pacific.

Gii, a distinct carbon-based 3D structure, is crafted by Integrated Graphene through a patented manufacturing process. This innovative nanomaterial enhances sensitivity and sustainability, revolutionising the functionality of commercial products. Integrated Graphene's clientele includes providers of point-of-care medical diagnostic tests, which, with the aid of Gii, can swiftly detect a variety of health conditions – from cardiovascular to neurological disorders –anywhere in the world.

Andrew brings a wealth of experience to his new role, with decades spent in operational leadership, manufacturing operations, and commercialisation. A chartered engineer, Andrew has designed and implemented complex manufacturing strategies for products ranging from textiles to automotive components. His prior roles include shaping a new multi-facility manufacturing base for Volvo Car Corporation and serving as General Manager of a $250 million division at Autoliv, one of the world’s largest safety suppliers, during his tenure in China. Since returning to the UK in 2017, after periods in Turkey, Sweden, and the UK, Andrew has been consulting for PwC, focusing on operational improvements and capital projects across various industries.

Andrew Lacey commented: “I am beyond excited to be joining Integrated Graphene at this crucial stage in its growth journey. Our highly skilled team has developed a truly unique material and proven its effective integration into customers’ products to revolutionise their performance. We are ready to sell Gii into multiple global markets, and I relish the opportunity to fine-tune our manufacturing approach and capabilities so that we are able to successfully scale and match the growing global demand, ensuring our customers can continue to lead their markets with unrivalled product performance.”

Jean-Christophe Granier, Chief Executive Officer at Integrated Graphene, added: “Andrew's appointment underscores Integrated Graphene's commitment to building a world-class leadership team capable of driving sustainable growth and delivering exceptional value to customers and partners. We are laser-focused on transforming point-of-care medical testing across the world, and I am delighted Andrew will be spearheading the development of our manufacturing capabilities to meet this mission.  

“His exceptional leadership skills and deep understanding of operational dynamics will be instrumental in accelerating our growth trajectory and strengthening our position as a global leader in graphene-based technologies.”